| Literature DB >> 30734541 |
He Huang1, Zhao-Fei Zhang1, Feng-Wei Qin1, Wang Tang1, Dong-Hua Liu1, Pei-Yu Wu1, Feng Jiao1.
Abstract
BACKGROUND: This study focused on the mechanisms where icariin inhibited chondrocyte apoptosis and angiogenesis by regulating the TDP-43 signaling pathway.Entities:
Keywords: TDP-43; VEGF; apoptosis; icariin; osteoarthritis
Mesh:
Substances:
Year: 2019 PMID: 30734541 PMCID: PMC6465670 DOI: 10.1002/mgg3.586
Source DB: PubMed Journal: Mol Genet Genomic Med ISSN: 2324-9269 Impact factor: 2.183
Figure 1Fluorescent quantitative PCR assays of gene in HC, MSCs‐HC, and TDP43‐HC
Figure 2Analysis of the positive rate of apoptosis in rat HC, MSCs‐HC, and TDP43‐HC cultured without icariin for 7 days
Figure 3Flow cytometric analysis of the positive rate of apoptotic cells by annexin V and propidium staining after rat TDP43‐HC was added with icariin for 7 days
Figure 4Flow cytometric analysis of the positive rate of apoptotic cells by annexin V and propidium staining after rat MSCs‐HC was added with icariin for 7 days
Figure 5Flow cytometric analysis of the positive rate of apoptotic cells by annexin V and propidium staining after rat HC was added with icariin for 7 days
Figure 6Growth curves of rat HC support culture in the presence of different doses of icariin
Figure 7Growth curves of rat MSCs‐HC support culture in the presence of different doses of icariin
Figure 8Growth curves of rat TDP43‐HC supporting culture in the presence of different doses of icariin
Expression level of VEGF and HIF‐1α in the CIA synvium
| Group | VEGF | HIF‐1α |
|---|---|---|
| Normal control | 17.64 ± 3.57## | 13.85 ± 1.51## |
| OA model | 168.43 ± 11.24** | 54.28 ± 2.69** |
| ICA(10 ng/ml) | 118.35 ± 9.21*# | 48.52 ± 3.65*# |
| ICA(20 ng/ml) | 69.58 ± 5.81*# | 33.27 ± 2.18*# |
| ICA(40 ng/ml) | 37.62 ± 3.64*# | 18.62 ± 1.71** |
**Compared to the control group, P < 0.05; ##compared to the OA model group P < 0.05; *#compared to control and OA group, P < 0.05.
Expression level of VEG and HIF‐1α in serum
| Group | VEGF | HIF‐1α |
|---|---|---|
| Normal control | 10.43 ± 1.14## | 3.85 ± 1.01## |
| OA model | 17.86 ± 1.42** | 5.27 ± 0.89** |
| ICA(10 ng/ml) | 16.34 ± 1.33## | 4.67 ± 0.75*# |
| ICA(20 ng/ml) | 14.27 ± 1.25*# | 3.29 ± 0.98## |
| ICA(40 ng/ml) | 10.55 ± 1.12** | 2.77 ± 0.61** |
**Compared to the control group, P < 0.05; ##compared to the OA model group P < 0.05; *#compared to control and OA group, P < 0.05.